Plasma granzyme B as a predicting factor of coronary artery disease-Clinical significance in patients with chronic renal failure

Journal of Cardiology

Volumn 54, Issue 3, 2009, Pages 409-415

  Ikemoto, Tomokazu ^a   Hojo, Yukihiro ^a   Kondo, Hideyuki ^a   Takahashi, Nozomu ^a   Hirose, Masahiro ^a   Nishimura, Yoshioki ^a   Katsuki, Takaaki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Atherosclerosis; Coronary artery disease; Cytokine

Indexed keywords

C REACTIVE PROTEIN; GRANZYME B;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN BLOOD LEVEL;

AGED; APOPTOSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; GLOMERULAR FILTRATION RATE; GRANZYMES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 70450222733     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.06.009     Document Type: Article

References (30)

1. Culleton B., Larson M., Wilson P., Evans J., Parfrey P., and Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56 (1999) 2214-2219
2. Le Feuvre C., Dambrin G., Helft G., Beygui F., Touam M., Grunfeld J., Vacheron A., and Metzger J. Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart 85 (2001) 556-560
3. Cottone S., Lorito M., Riccobene R., Nardi E., Mule G., Buscemi S., Geraci C., Guarneri M., Arsena R., and Cerasola G. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21 (2008) 175-179
4. Efstratiadis G., Tziomalos K., Mikhailidis D., Athyros V., and Hatzitolios A. Atherogenesis in renal patients: a model of vascular disease?. Curr Vasc Pharmacol 6 (2008) 93-107
5. Yeun J., and Kaysen G. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens 9 (2000) 621-630
6. Yi F., and Li P. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am J Nephrol 28 (2008) 54-64
7. Jha H., Srivastava P., Sarkar R., Prasad J., and Mittal A. Chlamydia pneumoniae IgA and elevated level of IL-6 may synergize to accelerate coronary artery disease. J Cardiol 52 (2008) 140-145
8. Ohkuma T., Minagawa T., Takada N., Ohno M., Oda H., and Ohashi H. C-reactive protein, lipoprotein (a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis 42 (2003) 355-361
9. Raj D., Dominic E., Pai A., Osman F., Morgan M., Pickett G., Shah V., Ferrando A., and Moseley P. Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. Kidney Int 68 (2005) 2338-2344
10. Maruyama Y., Nordfors L., Stenvinkel P., Heimburger O., Barany P., Pecoits-Filho R., Axelsson J., Hoff C., Holmes C., Schalling M., and Lindholm B. Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease. Blood Purif 23 (2005) 384-393
11. Raj D., Shah H., Shah V., Ferrando A., Bankhurst A., Wolfe R., and Zager P. Markers of inflammation, proteolysis, and apoptosis in ESRD. Am J Kidney Dis 42 (2003) 212-220
12. Tsuru R., Kondo H., Hojo Y., Gama M., Mizuno O., Katsuki T., Shimada K., Kikuchi M., and Yashiro T. Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndrome. Heart 94 (2008) 305-310
13. Heibein J., Goping I., Barry M., Pinkoski M., Shore G., Green D., and Bleackley R. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med 192 (2000) 1391-1402
14. Barry M., Heibein J., Pinkoski M., Lee S., Moyer R., Green D., and Bleackley R. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol 20 (2000) 3781-3794
15. Chamberlain C., and Granville D. The role of Granzyme B in atheromatous diseases. Can J Physiol Pharmacol 85 (2007) 89-95
16. Lamon B., and Hajjar D. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol 173 (2008) 1253-1264
17. Qin C., and Liu Z. In atherogenesis, the apoptosis of endothelial cell itself could directly induce over-proliferation of smooth muscle cells. Med Hypotheses 68 (2007) 275-277
18. Nairn J., Hodge G., and Henning P. Intracellular cytokines in peripheral blood leucocytes in children with chronic renal failure. Pediatr Nephrol 21 (2006) 251-256
19. Ramirez R., Martin-Malo A., and Aljama P. Inflammation and hemodiafiltration. Contrib Nephrol 158 (2007) 210-215
20. Ramirez R., Carracedo J., Merino A., Nogueras S., Alvarez-Lara M., Rodriguez M., Martin-Malo A., Tetta C., and Aljama P. Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int 72 (2007) 108-113
21. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 Suppl. (2002) S1-S266
22. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., and Hishida A. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53 (2009) 982-992
23. Ninomiya J., L'Italien G., Criqui M., Whyte J., Gamst A., and Chen R. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
24. Ledue T., Weiner D., Sipe J., Poulin S., Collins M., and Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 35 (1998) 745-753
25. Costa E., Lima M., Alves J., Rocha S., Rocha-Pereira P., Castro E., Miranda V., do S.F., Loureiro A., Quintanilha A., Belo L., and Santos-Silva A. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol 28 (2008) 268-275
26. Bosutti A., Grassi G., Fiotti N., Guarnieri G., and Biolo G. Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment. Cytokine 40 (2007) 71-74
27. Cottone S., Nardi E., Mule G., Vadala A., Lorito M., Riccobene R., Palermo A., Arsena R., Guarneri M., and Cerasola G. Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol 67 (2007) 209-216
28. Choy J., Cruz R., Kerjner A., Geisbrecht J., Sawchuk T., Fraser S., Hudig D., Bleackley R., Jirik F., McManus B., and Granville D. Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease. Am J Transplant 5 (2005) 494-499
29. Bot I., von der Thusen J., Donners M., Lucas A., Fekkes M., de Jager S., Kuiper J., Gattobigio R., Filippucci L., Daemen M., van Berkel T., Heeneman S., and Biessen E. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. Circ Res 93 (2003) 464-471
30. Bedard E., Jiang J., Arp J., Qian H., Wang H., Guan H., Liu L., Parry N., Kim P., Garcia B., Li X., Macaulay C., McFadden G., Lucas A., and Zhong R. Prevention of chronic renal allograft rejection by SERP-1 protein. Transplantation 81 (2006) 908-914